arrow
N

Neil Keshvani

ut southwestern medical center
H指数:16
被引数:784

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A polypill strategy for lipid lowering and anti-platelet therapy after acute coronary syndrome: A pilot randomized controlled trial

一种用于急性冠状动脉综合征后降脂和抗血小板治疗的复方制剂策略:一项试点随机对照试验

2026-03-070
OAAI
Rationale, Design, and Baseline Characteristics of the Polypill for Heart Failure with Reduced Ejection Fraction (POLY-HF) Trial

背景、设计与基线特征:心力衰竭伴射血分数降低的复方制剂试验(POLY-HF试验)

2025-10-310
PRE
Sex differences in NT-proBNP associations with risk of heart failure subtypes and response to an intensive lifestyle intervention in type 2 diabetes and overweight or obesity: a post-hoc analysis of the Look AHEAD trial

NT-proBNP与心力衰竭亚型风险及对强化生活方式干预的反应在2型糖尿病和超重或肥胖中的性别差异:Look AHEAD试验的事后分析

2025-10-060
PRE
Remote Optimization of Guideline-Directed Medical Therapy Using Home Monitoring in Heart Failure: The GOALS-HF Study

利用家庭监测对心力衰竭患者进行指南指导的医疗治疗远程优化:GOALS-HF 研究

2025-05-200
PRE
Impact of Metabolic Dysfunction–associated Steatotic Liver Disease on Cardiovascular Structure, Function, and the Risk of Heart Failure

Bansal, B.; Lajeunesse-Trempe, F.; Keshvani, N.; Lavie, C.J.; Pandey, A. 代谢功能障碍相关脂肪性肝病对心血管结构、功能及心力衰竭风险的影响。Can. J. Cardiol. 2025. [Google Scholar] [CrossRef]

2025-04-190
PRE